Speaker illustration

Professor Ping-Yen Liu

National Cheng Kung University Hospital, Tainan (Taiwan)

Member of:

European Society of Cardiology

Dr Ping-Yen Liu is the Director and a Professor of Medicine and Institute of Clinical Medicine, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan. He is also a professor of Cardiology, Internal Medicine, in the NCKU Hospital. He is currently the dupty editor of the Acta Cardiologica Sinica (ACS, Impact factor 2.1 in 2020 JCR), the official Journal of Taiwan Society of Cardiology since 2012. He also co-chairs the Committee of International Affairs in the Taiwan Society of Cardiology since 2018. Dr Liu’s research work focused on the pathophysiology of cardiovascular disease, with an emphasis on dyslipidemia, thrombosis and hemostasis, platelet function, rho kinase activity, etc. Dr. Liu has published 170 peer reviewed research papers and has an h-index of 27. He actively supervises 20+ doctoral students and graduate students and clinical researchers in NCKU.

The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan

Event: ESC Congress 2025

Topic: Drug therapy

Session: Drug therapy (1)

Thumbnail

Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study

Event: ESC Congress 2025

Topic: Cardiovascular Pharmacotherapy

Session: Cardiotoxicity and protection: from bench to bedside

Thumbnail

The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension

Event: ESC Congress 2025

Topic: Pulmonary Hypertension

Session: Pathobiology of pulmonary hypertension

Thumbnail

Highlights from FINEARTS-HF and FINE-HEART: the role of finerenone in heart failure

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session: Daily Highlights by the Taiwan Society of Cardiology

Thumbnail

Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside

Event: ESC Congress 2024

Topic: Obesity

Session: Nutrition and heart disease

Thumbnail

Rho kinase pathway is crucial for platelet activation in the culprit coronary artery microenvironment during an acute coronary syndrome event: a clinical and platelet ribosome profile sequencing study

Event: ESC Congress 2017

Topic: Platelets

Session: Cardiovascular cell biology

Thumbnail

CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy

Event: ESC Congress 2016

Topic: Cardiotoxicity of drugs

Session: Cancer and cardiotoxicity: from bench to bedside

Thumbnail